The mechanisms by which neurons respond to inflammatory mediators such as interferons (IFNs) remain largely undefined. We previously showed that the activation and nuclear localization of the core IFN signaling molecule, Stat1, are muted and delayed in primary mouse hippocampal neurons treated with IFN gamma as compared to control mouse embryonic fibroblasts (MEFs). Here, we show that the kinetics of Stat1 and Stat2 activation following type I IFN exposure are also unique in neurons, affecting gene expression and neuronal response. Specifically, despite lower basal expression of many IFN stimulated genes in neurons, basal expression of the type I IFN themselves is significantly higher in primary hippocampal neurons compared to MEF. Elevated homeostatic IFN in neurons is critical and sufficient for early control of viral infection. These data provide further evidence that neurons exploit unique signaling responses to IFNs, and define an important contribution of homeostatic IFN within the CNS. Such differences are likely critical for the ability of neurons to survive a viral challenge.
Introduction
The host immune response can efficiently resolve certain neurotropic infections, but unregulated or chronic immune responses in the central nervous system (CNS) can be pathogenic and often fatal. Immune dysregulation within the brain can result in encephalitis and meningitis, and contributes to many chronic neuroinflammatory diseases such as multiple sclerosis (Kundig et al., 1993; Binder and Griffin, 2001; Dorries, 2001; Griffin and Metcalf, 2011; Smith et al., 2012; Wilms et al., 2007) . Therefore, a balance must be achieved in which pathogen control or clearance is achieved with minimal neuropathology. This is particularly relevant for infections of CNS neurons, which are a chiefly non-renewable cell population. Well-defined immune mechanisms that clear viral infections in the periphery, including perforins and granzymes, are underutilized in the brain, perhaps protecting the neuronal population from immune-mediated cytolysis. Instead, cytokines, including the interferons (IFNs), are fundamental contributors to CNS virus clearance. Thus, an overarching goal of our studies is to elucidate the unique interactions of IFNs with neuronal targets, and to define how the consequences of IFN signaling limit or clear neurotropic infections in the absence of CNS disease.
Viral reproduction in the CNS is a relatively rare, albeit serious, outcome of infection by a number of human viruses. While some viruses are well-known to be neurotropic (e.g., poliovirus, rabies virus, West Nile virus, and some herpesviruses), others that are primarily associated with peripheral infections, including influenza and measles, can also result in life-threatening CNS complications (Johnson, 1998) . For example, influenza has been associated with encephalitis, Reye's syndrome, and acute necrotizing encephalopathy, particularly in children (Studahl, 2003) . Moreover, measles virus (MV) infection of CNS neurons is associated with invariably fatal diseases such as subacute sclerosing panencephalitis, which can occur months to years after primary virus exposure (Dubois-Dalcq et al., 1974) . While some of these viruses gain access to the brain parenchyma due to a weakened immune response (e.g., herpesviruses), most result in neuropathology via induction of the immune response (James et al., 2009 ).
An early and essential line of defense against viral infection is the induction of interferons (IFNs) that ultimately leads to antiviral gene expression (reviewed in Stark et al., 1998) . Briefly, in most mammalian cells, viruses are detected by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and retinoic acid-inducible gene-I (Rig-I). Recognition of viral nucleic acid in infected cells by these receptors leads to downstream signaling, including activation of transcription factors NF-kB and IFN-regulatory factors 3 and 7 (Irf3, Irf7). Migration of these transcription factors into the nucleus induces expression of genes encoding type I IFNs (IFNα, IFNβ). Once released from the cell, IFNs then ⁎ Corresponding author. E-mail address: glenn.rall@fccc.edu (G.F. Rall).
